{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:00:08Z","timestamp":1794384008488,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":148,"publisher":"Springer New York","isbn-type":[{"value":"9781441963536","type":"print"},{"value":"9781441963543","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-4419-6354-3_6","type":"book-chapter","created":{"date-parts":[[2011,1,9]],"date-time":"2011-01-09T00:36:53Z","timestamp":1294533413000},"page":"71-87","source":"Crossref","is-referenced-by-count":28,"title":["Melanocortins and the Cholinergic Anti-Inflammatory Pathway"],"prefix":"10.1007","author":[{"given":"Daniela","family":"Giuliani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ottani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Altavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Bazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Squadrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Guarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"6_CR1","first-page":"859","volume":"31","author":"W. Ferrari","year":"1955","unstructured":"Ferrari W, Floris E, Paulesu F. Eosinopenic effect of ACTH injected into the cisterna magna. Boll Soc It Biol Sper 1955; 31:859\u2013862.","journal-title":"Boll Soc It Biol Sper"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/181925a0","volume":"181","author":"W. Ferrari","year":"1958","unstructured":"Ferrari W. Behavioural changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte-stimulating hormone. Nature 1958; 181:925\u2013926.","journal-title":"Nature"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1749-6632.1963.tb17677.x","volume":"104","author":"W. Ferrari","year":"1963","unstructured":"Ferrari W, Gessa GL, Vargiu L. Behavioral effects induced by intracisternally injected ACTH and MSH. Ann NY Acad Sci 1963; 104:330\u2013345.","journal-title":"Ann NY Acad Sci"},{"key":"6_CR4","first-page":"97","volume-title":"Frontiers in Neuroendocrinology","author":"D. Wied De","year":"1969","unstructured":"De Wied D. Effect of peptide hormones on behavior. In: Ganon WF, Martini L, eds. Frontiers in Neuroendocrinology, London\/New York: Oxford University Press, 1969; 1:97\u2013140."},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.tins.2008.04.002","volume":"31","author":"A. Catania","year":"2008","unstructured":"Catania A. Neuroprotective action of melanocortins: a therapeutic opportunity. Trends Neurosci 2008; 31:353\u2013360.","journal-title":"Trends Neurosci"},{"key":"6_CR6","unstructured":"Eberle AN. The melanotropins: chemistry, physiology and mechanisms of action. Basel: Karger, 1988."},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.06.022","volume":"111","author":"S.J. Getting","year":"2006","unstructured":"Getting SJ. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 2006; 111:1\u201315.","journal-title":"Pharmacol Ther"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0196-9781(82)90098-5","volume":"3","author":"T.I. O\u2019Donohue","year":"1982","unstructured":"O\u2019Donohue TI, Dorsa DM. The opiomelanotropinergic neuronal and endocrine systems. Peptides 1982; 3:353\u2013395.","journal-title":"Peptides"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1210\/edrv-9-1-159","volume":"9","author":"A.I. Smith","year":"1988","unstructured":"Smith AI, Funder JW. Proopiomelanocortin processing in the pituitary, central nervous system and peripheral tissues. Endocrinol Rev 1988; 9:159\u2013179.","journal-title":"Endocrinol Rev"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(98)00615-3","volume":"360","author":"D.H.G. Versteeg","year":"1998","unstructured":"Versteeg DHG, Van Bergen P, Adan RAH et al. Melanocortins and cardiovascular regulation. Eur J Pharmacol 1998; 360:1\u201314.","journal-title":"Eur J Pharmacol"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.56.1.1","volume":"56","author":"A. Catania","year":"2004","unstructured":"Catania A, Gatti S, Colombo G et al. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 2004; 56:1\u201329.","journal-title":"Pharmacol Rev"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejphar.2005.12.023","volume":"532","author":"S.J. Getting","year":"2006","unstructured":"Getting SJ, Di Filippo C, D\u2019Amico M et al. The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage. Eur J Pharmacol 2006; 532:138\u2013144.","journal-title":"Eur J Pharmacol"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd2331","volume":"7","author":"J.E. Wikberg","year":"2008","unstructured":"Wikberg JE, Mutulis F. Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction. Nat Rev Drug Discov 2008; 7:307\u2013323.","journal-title":"Nat Rev Drug Discov"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1126\/science.1325670","volume":"257","author":"K.G. Mountjoy","year":"1992","unstructured":"Mountjoy KG, Robbins LS, Mortrud MT et al. The cloning of a family of genes that encode the melanocortin receptors. Science 1992; 257:1248\u20131251.","journal-title":"Science"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1210\/en.2003-0570","volume":"144","author":"K.G. Mountjoy","year":"2003","unstructured":"Mountjoy KG, Wu C-SJ, Dumont LM et al. Melanocortin-4 receptor messenger ribonucleic acid expression in rat cardiorespiratory, musculoskeletal and in tegumentary systems. Endocrinology 2003; 144:5488\u20135496.","journal-title":"Endocrinology"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0083-6729(01)63007-3","volume":"63","author":"H.B. Schi\u00f6th","year":"2001","unstructured":"Schi\u00f6th HB. The physiological role of melanocortin receptors. Vitam Horm 2001; 63:195\u2013232.","journal-title":"Vitam Horm"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/j.peptides.2004.11.034","volume":"26","author":"H.B. Schi\u00f6th","year":"2005","unstructured":"Schi\u00f6th HB, Haitina T, Ling MK et al. Evolutionary conservation of the structural, pharmacological and genomic characteristics of the melanocortin receptor subtypes. Peptides 2005; 26:1886\u20131900.","journal-title":"Peptides"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0006-8993(90)90016-5","volume":"536","author":"J.B. Tatro","year":"1990","unstructured":"Tatro JB. Melanotropin receptors in the brain are differentially distributed and recognize both corticotrophin and alpha-melanocyte stimulating hormone. Brain Res 1990; 536:124\u2013132.","journal-title":"Brain Res"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1749-6632.1994.tb19833.x","volume":"739","author":"J.B. Tatro","year":"1994","unstructured":"Tatro JB, Entwistle ML. Distribution of melanocortin receptors in the lower brainstem of the rat. Ann NY Acad Sci 1994; 739:311\u2013314.","journal-title":"Ann NY Acad Sci"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000097281","volume":"3","author":"J.B. Tatro","year":"1996","unstructured":"Tatro JB. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation 1996; 3:259\u2013284.","journal-title":"Neuroimmunomodulation"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1006\/phrs.2000.0725","volume":"42","author":"J.E.S. Wikberg","year":"2000","unstructured":"Wikberg JES, Muceniece R, Mandrika I et al. New aspects on the melanocortins and their receptors. Pharmacol Res 2000; 42:393\u2013420.","journal-title":"Pharmacol Res"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2007-0027","volume":"29","author":"T. Brzoska","year":"2008","unstructured":"Brzoska T, Luger TA, Maser C et al. \u03b1-Melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in Vitro and in Vivo and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 2008; 29:581\u2013602.","journal-title":"Endocr Rev"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.peptides.2008.06.009","volume":"29","author":"M. Lasaga","year":"2008","unstructured":"Lasaga M, Debeljuk L, Durand D et al. Role of alpha-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation. Peptides 2008; 29:1825\u20131835.","journal-title":"Peptides"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.eururo.2003.03.001","volume":"45","author":"W.J. Martin","year":"2004","unstructured":"Martin WJ, MacIntyre DE. Melanocortin receptors and erectile function. Eur Urol 2004; 45:706\u2013713.","journal-title":"Eur Urol"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/en.2005-1573","volume":"147","author":"J.B. Tatro","year":"2006","unstructured":"Tatro JB. Melanocortins defend their territory: multifaceted neuroprotection in cerebral ischemia. Endocrinology 2006; 147:1122\u20131125.","journal-title":"Endocrinology"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0014-2999(86)90424-3","volume":"122","author":"A. Bertolini","year":"1986","unstructured":"Bertolini A, Guarini S, Ferrari W. Adrenal-independent, anti-shock effect of ACTH-(1\u201324) in rats. Eur J Pharmacol 1986; 122:387\u2013388.","journal-title":"Eur J Pharmacol"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0014-2999(86)90179-2","volume":"130","author":"A. Bertolini","year":"1986","unstructured":"Bertolini A, Guarini S, Rompianesi E et al. \u03b1-MSH and other ACTH fragments improve cardiovascular function and survival in experimental hemorrhagic shock. Eur J Pharmacol 1986; 130:19\u201326.","journal-title":"Eur J Pharmacol"},{"key":"6_CR28","first-page":"311","volume":"289","author":"S. Guarini","year":"1987","unstructured":"Guarini S, Ferrari W, Mottillo G et al. Anti-shock effect of ACTH: haematological changes and influence of splenectomy. Arch In Pharmacodyn 1987; 289:311\u2013318.","journal-title":"Arch In Pharmacodyn"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1097\/00003246-199008000-00014","volume":"18","author":"S. Guarini","year":"1990","unstructured":"Guarini S, Tagliavini S, Bazzani C et al. Early treatment with ACTH-(1\u201324) in a rat model of hemorrhagic shock prolongs survival and extends the time-limit for blood reinfusion to be effective. Crit Care Med 1990; 18:862\u2013865.","journal-title":"Crit Care Med"},{"key":"6_CR30","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-3565(24)35205-X","volume":"291","author":"S. Guarini","year":"1999","unstructured":"Guarini S, Bazzani C, Cainazzo MM et al. Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides. J Pharmacol Exp Ther 1999; 291:1023\u20131027.","journal-title":"J Pharmacol Exp Ther"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cardiores.2004.03.029","volume":"63","author":"S. Guarini","year":"2004","unstructured":"Guarini S, Cainazzo MM, Giuliani D et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 2004; 63:357\u2013365.","journal-title":"Cardiovasc Res"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.bjp.0707115","volume":"150","author":"D. Giuliani","year":"2007","unstructured":"Giuliani D, Mioni C, Bazzani C et al. Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage. Br J Pharmacol 2007; 150:595\u2013603.","journal-title":"Br J Pharmacol"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(01)05631-8","volume":"358","author":"G. Noera","year":"2001","unstructured":"Noera G, Lamarra M, Guarini S et al. Survival rate after early treatment for acute type-A aortic dissection with ACTH-(1\u201324). Lancet 2001; 358:469\u2013470.","journal-title":"Lancet"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.bjp.0702848","volume":"128","author":"F. Squadrito","year":"1999","unstructured":"Squadrito F, Guarini S, Altavilla D et al. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock. Br J Pharmacol 1999; 128:816\u2013822.","journal-title":"Br J Pharmacol"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/sj.bjp.0701264","volume":"121","author":"S. Guarini","year":"1997","unstructured":"Guarini S, Bazzani C, Bertolini A. Resuscitating effect of melanocortin peptides after prolonged respiratory arrest. Br J Pharmacol 1997; 121:1454\u20131460.","journal-title":"Br J Pharmacol"},{"key":"6_CR36","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0022-3565(24)29636-1","volume":"297","author":"C. Bazzani","year":"2001","unstructured":"Bazzani C, Guarini S, Botticelli AR et al. Protective effect of melanocortin peptides in rat myocardial ischemia. J Pharmacol Exp Ther 2001; 297:1082\u20131087.","journal-title":"J Pharmacol Exp Ther"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00210-002-0572-8","volume":"366","author":"S. Guarini","year":"2002","unstructured":"Guarini S, Schi\u00f6th HB, Mioni C et al. MC3 receptors are involved in the protective effect of melanocortins in myocardial ischaemia\/reperfusion-induced arrhythmias. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 2002; 366:177\u2013182.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1189\/jlb.0306175","volume":"76","author":"S.J. Getting","year":"2004","unstructured":"Getting SJ, Di Filippo C, Christian HC et al. MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct. J Leukoc Biol 2004; 76:845\u2013853.","journal-title":"J Leukoc Biol"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0014-2999(03)02184-8","volume":"477","author":"C. Mioni","year":"2003","unstructured":"Mioni C, Giuliani D, Cainazzo MM et al. Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors. Eur J Pharmacol 2003; 477:227\u2013234.","journal-title":"Eur J Pharmacol"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1097\/01.CCM.0000186762.05301.13","volume":"33","author":"C. Mioni","year":"2005","unstructured":"Mioni C, Bazzani C, Giuliani D et al. Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia\/reperfusion injury in rats. Crit Care Med 2005; 33:2621\u20132628.","journal-title":"Crit Care Med"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0014-2999(03)01780-1","volume":"470","author":"M. Vecsernyes","year":"2003","unstructured":"Vecsernyes M, Juhasz B, Der P et al. The administration of \u03b1-melanocyte-stimulating hormone protects the ischemic\/reperfused myocardium. Eur J Pharmacol 2003; 470:177\u2013183.","journal-title":"Eur J Pharmacol"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1172\/JCI119272","volume":"99","author":"H. Chiao","year":"1997","unstructured":"Chiao H, Kohda Y, McLeroy P et al. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997; 99:1165\u20131172.","journal-title":"J Clin Invest"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.transproceed.2008.07.101","volume":"40","author":"Y.S. Lee","year":"2008","unstructured":"Lee YS, Park JJ, Chung KY. Change of melanocortin receptor expression in rat kidney ischemia-reperfusion injury. Transplant Proc 2008; 40:2142\u20132144.","journal-title":"Transplant Proc"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/ndt\/16.8.1583","volume":"16","author":"S.K. Jo","year":"2001","unstructured":"Jo SK, Yun SY, Chang KH et al. \u03b1-MSH decreases apoptosis in ischaemic acute renal failure in rats: possibile mechanism of this beneficial effect. Nephrol Dial Transplant 2001; 16:1583\u20131591.","journal-title":"Nephrol Dial Transplant"},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1210\/en.2005-0692","volume":"147","author":"D. Giuliani","year":"2006","unstructured":"Giuliani D, Mioni C, Altavilla D et al. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 2006; 147:1126\u20131135.","journal-title":"Endocrinology"},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2006.03.038","volume":"538","author":"D. Giuliani","year":"2006","unstructured":"Giuliani D, Leone S, Mioni C et al. Broad therapeutic treatment window of the [Nle4, D-Phe7] \u03b1-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils. Eur J Pharmacol 2006; 538:48\u201356.","journal-title":"Eur J Pharmacol"},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejphar.2007.05.025","volume":"570","author":"D. Giuliani","year":"2007","unstructured":"Giuliani D, Ottani A, Mioni C et al. Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. Eur J Pharmacol 2007; 570:57\u201365.","journal-title":"Eur J Pharmacol"},{"key":"6_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.npep.2008.01.004","volume":"42","author":"G. Chen","year":"2008","unstructured":"Chen G, Fr\u00f8ki\u00e6r J, Pedersen M et al. Reduction of ischemic stroke in rat brain by alpha melanocyte stimulating hormone. Neuropeptides 2008; 42:331\u2013338.","journal-title":"Neuropeptides"},{"key":"6_CR49","unstructured":"Ottani A, Giuliani D, Mioni C et al. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. J Cereb Blood Flow Metab 2008; doi:10.1038\/ jcbfm.2008.140."},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1097\/00007890-200212270-00005","volume":"74","author":"S. Gatti","year":"2002","unstructured":"Gatti S, Colombo G, Buffa R et al. \u03b1-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 2002; 74:1678\u20131684.","journal-title":"Transplantation"},{"key":"6_CR51","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/35013070","volume":"405","author":"L.V. Borovikova","year":"2000","unstructured":"Borovikova LV, Ivanova S, Zhang M et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458\u2013462.","journal-title":"Nature"},{"key":"6_CR52","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"K.J. Tracey","year":"2002","unstructured":"Tracey KJ. The inflammatory reflex. Nature 2002; 420:853\u2013859.","journal-title":"Nature"},{"key":"6_CR53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1172\/JCI30555","volume":"117","author":"K.J. Tracey","year":"2007","unstructured":"Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117:289\u2013296.","journal-title":"J Clin Invest"},{"key":"6_CR54","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1213\/01.ane.0000244532.71743.c6","volume":"103","author":"K.W. Hatton","year":"2006","unstructured":"Hatton KW, McLarney JT, Pittman T et al. Vagal nerve stimulation: overview and implications for anesthesiologists. Anesth Analg 2006; 103:1241\u20131249.","journal-title":"Anesth Analg"},{"key":"6_CR55","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1358\/dot.2004.40.6.850483","volume":"40","author":"J.W. Wheless","year":"2004","unstructured":"Wheless JW, Baumgartner J. Vagus nerve stimulation therapy. Drugs Today 2004; 40:501\u2013515.","journal-title":"Drugs Today"},{"key":"6_CR56","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1126\/science.3014662","volume":"233","author":"H. Basedovsky","year":"1986","unstructured":"Basedovsky H, Rey DA, Sorkin E et al. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986; 233:652\u2013654.","journal-title":"Science"},{"key":"6_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0165-5728(91)90084-K","volume":"31","author":"X.X. Hu","year":"1991","unstructured":"Hu XX, Goldmuntz EA, Brosnan CF. The effect of norepinephrine on endotoxin-mediated macrophage activation. J Neuroimmunol 1991; 31:35\u201342.","journal-title":"J Neuroimmunol"},{"key":"6_CR58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0167-5699(97)01009-8","volume":"18","author":"J.M. Lipton","year":"1997","unstructured":"Lipton JM, Catania A. Antiinflammatory action of neuroimmunomodulator \u03b1-MSH. Immunol Today 1997; 18:140\u2013145.","journal-title":"Immunol Today"},{"key":"6_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1566-0702(00)00219-8","volume":"85","author":"L.E. Goehler","year":"2000","unstructured":"Goehler LE, Gaykema RP, Hansen MK et al. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci 2000; 85:49\u201359.","journal-title":"Auton Neurosci"},{"key":"6_CR60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1152\/ajpregu.2001.280.1.R289","volume":"208","author":"G.E. Herman","year":"2001","unstructured":"Herman GE, Emch GS, Tovar CA et al. c-Fos generation in the dorsal vagal complex after systemic endotoxin is not dependent on the vagus nerve. Am J Physiol Regul Integr Comp Physiol 2001; 208:289\u2013299.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"6_CR61","doi-asserted-by":"crossref","first-page":"G582","DOI":"10.1152\/ajpgi.2000.279.3.G582","volume":"279","author":"G.S. Emch","year":"2000","unstructured":"Emch GS, Herman GE, Rogers RC. TNF-\u03b1 activates solitary nucleus neurons responsive to gastric distension. Am J Physiol Gastrointest Liver Physiol 2000; 279:G582\u2013G586.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.96.14.7710","volume":"96","author":"L.R. Watkins","year":"1999","unstructured":"Watkins LR, Maier SF. Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA 1999; 96:7710\u20137713.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR63","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1172\/JCI119807","volume":"100","author":"E.M. Stenberg","year":"1997","unstructured":"Stenberg EM. Neural-immune interactions in health and disease. J Clin Invest 1997; 100:2641\u20132647.","journal-title":"J Clin Invest"},{"key":"6_CR64","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1126\/science.270.5234.283","volume":"270","author":"R.I. Scheimann","year":"1995","unstructured":"Scheimann RI, Cogswell PC, Lofquist AK et al. Role of trancriptional activation of IkB \u03b1 in mediation of immunosuppression by glucocorticoids. Science 1995; 270:283\u2013286.","journal-title":"Science"},{"key":"6_CR65","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/01.CIR.0000050627.90734.ED","volume":"107","author":"S. Guarini","year":"2003","unstructured":"Guarini S, Altavilla D, Cainazzo MM et al. Efferent vagal fibre stimulation blunts nuclear factor-kB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003, 107:1189\u2013119.","journal-title":"Circulation"},{"key":"6_CR66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00179049","volume":"343","author":"S. Guarini","year":"1991","unstructured":"Guarini S, Tagliavini S, Bazzani C et al. Nicotine reverses hemorrhagic shock in rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 1991; 343:427\u2013430.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"6_CR67","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/BF02118314","volume":"48","author":"S. Guarini","year":"1992","unstructured":"Guarini S, Bazzani C, Tagliavini S et al. Reversal of experimental hemorrhagic shock by dimethylphenylpiperazinium (DMPP). Experientia 1992; 48:663\u2013667.","journal-title":"Experientia"},{"key":"6_CR68","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bbi.2005.03.015","volume":"19","author":"V.A. Pavlov","year":"2005","unstructured":"Pavlov VA, Tracey KJ. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005; 19:493\u2013499.","journal-title":"Brain Behav Immun"},{"key":"6_CR69","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1189\/jlb.0607363","volume":"83","author":"S.L. Oke","year":"2008","unstructured":"Oke SL, Tracey KJ. From CNI-1493 to the immunological homonculus: physiology of the inflammatory reflex. J Leukoc Biol 2008; 83:512\u2013517.","journal-title":"J Leukoc Biol"},{"key":"6_CR70","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1196\/annals.1418.011","volume":"1144","author":"W.R. Parrish","year":"2008","unstructured":"Parrish WR, Gallowitsch-Puerta M, Czura CJ et al. Experimental therapeutic strategies for severe sepsis: mediators and mechanisms. Ann N Y Acad Sci 2008; 1144:210\u2013236.","journal-title":"Ann N Y Acad Sci"},{"key":"6_CR71","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2982.2008.01252.x","volume":"21","author":"E.P. Zanden Van der","year":"2009","unstructured":"Van der Zanden EP, Boeckxstaens Ge, de Jonge WJ. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol Motil 2009; 21:6\u201317.","journal-title":"Neurogastroenterol Motil"},{"key":"6_CR72","unstructured":"Loewy AD. Central autonomic pathways. In: Loewy AD, Spyer KM, eds. Central Regulation of Autonomic Functions. Oxford: Oxford University Press, 1990:88\u2013104."},{"key":"6_CR73","first-page":"703","volume":"132","author":"A.E. Baue","year":"1997","unstructured":"Baue AE. Multiple organ failure, multiple organ dysfunction syndrome and systemic inflammatory response syndrome. Why no magic bullets? Arch Surg 1997; 132:703\u2013707.","journal-title":"Why no magic bullets? Arch Surg"},{"key":"6_CR74","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1172\/JCI119314","volume":"99","author":"Y. Tulzo Le","year":"1997","unstructured":"Le Tulzo Y, Shenkar R, Kaneko D et al. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kB regulation and cytokine expression. J Clin Invest 1997; 99:1516\u20131524.","journal-title":"J Clin Invest"},{"key":"6_CR75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1476-5381.1996.tb15673.x","volume":"119","author":"S. Guarini","year":"1996","unstructured":"Guarini S, Bazzani C, Mattera Ricigliano G et al. Influence of ACTH-(1\u201324) on free radical levels in the blood of haemorrhage-shocked rats: direct ex vivo detection by electron spin resonance spectrometry. Br J Pharmacol 1996; 119:29\u201334.","journal-title":"Br J Pharmacol"},{"key":"6_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0014-2999(97)01210-7","volume":"336","author":"S. Guarini","year":"1997","unstructured":"Guarini S, Bini A, Bazzani C et al. Adrenocorticotropin normalizes the blood levels of nitric oxide in haemorrhage-shocked rats. Eur J Pharmacol 1997; 336:15\u201321.","journal-title":"Eur J Pharmacol"},{"key":"6_CR77","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/01.shk.0000209539.91553.82","volume":"25","author":"D. Altavilla","year":"2006","unstructured":"Altavilla D, Guarini S, Bitto A et al. Activation of the cholinergic anti-infiammatory pathway reduces NF-kB activation, blunts TNF-\u03b1 production and protects against splanchnic artery occlusion shock. Shock 2006; 25:500\u2013506.","journal-title":"Shock"},{"key":"6_CR78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1096\/fj.99-0645com","volume":"15","author":"M.C. McDonald","year":"2001","unstructured":"McDonald MC, Mota-Filipe H, Paul A et al. Calpain inhibitor I reduces the activation of nuclear factor-kB and organ injury\/dysfunction in hemorrhagic shock. FASEB J 2001; 15:171\u2013186.","journal-title":"FASEB J"},{"key":"6_CR79","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/01.CCM.0000153416.41398.A9","volume":"33","author":"X. Cui","year":"2005","unstructured":"Cui X, Wu R, Zhou M et al. Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. Crit Care Med 2005; 33:391\u2013398.","journal-title":"Crit Care Med"},{"key":"6_CR80","first-page":"575","volume":"4","author":"D. Jarrar","year":"1999","unstructured":"Jarrar D, Chaudry IH, Wang P. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches. Int J Mol Med 1999; 4:575\u2013583.","journal-title":"Int J Mol Med"},{"key":"6_CR81","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/0024-3205(86)90188-8","volume":"39","author":"A. Bertolini","year":"1986","unstructured":"Bertolini A, Guarini S, Ferrari W et al. Adrenocorticotropin reversal of experimental hemorrhagic shock is antagonized by morphine. Life Sci 1986; 39:1271\u20131280.","journal-title":"Life Sci"},{"key":"6_CR82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0031-6989(87)90068-3","volume":"19","author":"S. Guarini","year":"1987","unstructured":"Guarini S, Vergoni AV, Bertolini A. Anti-shock effect of ACTH-(1\u201324): comparison between intracerebroventricular and intravenous route of administration. Pharmacol Res Commun 1987; 19:255\u2013260.","journal-title":"Pharmacol Res Commun"},{"key":"6_CR83","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0300-9572(89)90006-3","volume":"18","author":"S. Guarini","year":"1989","unstructured":"Guarini S, Tagliavini S, Bazzani C et al. Effect of ACTH-(1\u201324) on the volume of circulating blood and on regional blood flow in rats bled to hypovolemic shock. Resuscitation 1989; 18:133\u2013134.","journal-title":"Resuscitation"},{"key":"6_CR84","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0300-9572(92)90196-J","volume":"23","author":"C. Bazzani","year":"1992","unstructured":"Bazzani C, Tagliavini S, Bertolini E et al. Influence of ACTH-(1\u201324) on metabolic acidosis and hypoxemia induced by massive hemorrhage in rats. Resuscitation 1992; 23:113\u2013120.","journal-title":"Resuscitation"},{"key":"6_CR85","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0031-6989(88)80015-8","volume":"20","author":"S. Guarini","year":"1988","unstructured":"Guarini S, Ferrari W, Bertolini A. Anti-shock effect of ACTH-(1\u201324): influence of subtotal hepatectomy. Pharmacol Res Commun 1988; 20:395\u2013403.","journal-title":"Pharmacol Res Commun"},{"key":"6_CR86","first-page":"57","volume":"55","author":"J. Jochem","year":"2004","unstructured":"Jochem J. Involvement of proopiomelanocortin-derived peptides in endogenous central istamine-induced reversal of critical haemorrhagic hypotension in rats. J Physiol Pharmacol 2004; 55:57\u201371.","journal-title":"J Physiol Pharmacol"},{"key":"6_CR87","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/10739680490425930","volume":"11","author":"S. Bertuglia","year":"2004","unstructured":"Bertuglia S, Giusti A. Influence of ACTH-(1\u201324) and plasma hyperviscosity on free radical production and capillary perfusion after hemorrhagic shock. Microcirculation 2004; 11:227\u2013238.","journal-title":"Microcirculation"},{"key":"6_CR88","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0014-2999(95)00003-4","volume":"275","author":"J. Ludbrook","year":"1995","unstructured":"Ludbrook J, Ventura S. ACTH-(1\u201324) blocks the decompensatory phase of the haemodynamic response to acute hypovolaemia in conscious rabbits. Eur J Pharmacol 1995; 275:267\u2013275.","journal-title":"Eur J Pharmacol"},{"key":"6_CR89","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/BF00637684","volume":"32","author":"A. Bertolini","year":"1987","unstructured":"Bertolini A, Guarini S, Ferrari W et al. ACTH-(1\u201324) restores blood pressure in acute hypovolaemia and haemorrhagic shock in humans. Eur J Clin Pharmacol 1987; 32:537\u2013538.","journal-title":"Eur J Clin Pharmacol"},{"key":"6_CR90","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0300-9572(89)90010-5","volume":"18","author":"G. Noera","year":"1989","unstructured":"Noera G, Pensa P, Guelfi P et al. ACTH-(1\u201324) and hemorrhagic shock: preliminary clinical results. Resuscitation 1989; 18:145\u2013147.","journal-title":"Resuscitation"},{"key":"6_CR91","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0300-9572(91)90002-G","volume":"22","author":"G. Noera","year":"1991","unstructured":"Noera G, Angiello L, Biagi B et al. Haemorrhagic shock in cardiac surgery. Pharmacological treatment with ACTH (1\u201324). Resuscitation 1991; 22:123\u2013127.","journal-title":"Resuscitation"},{"key":"6_CR92","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0300-9572(89)90011-7","volume":"18","author":"G. Pinelli","year":"1989","unstructured":"Pinelli G, Chesi G, Di Donato C et al. Preliminary data on the use of ACTH-(1\u201324) in human shock conditions. Resuscitation 1989; 18:149\u2013150.","journal-title":"Resuscitation"},{"key":"6_CR93","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/sj.bjp.0702038","volume":"124","author":"D. Altavilla","year":"1998","unstructured":"Altavilla D, Cainazzo MM, Squadrito F et al. Tumour necrosis factor-\u03b1 as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat. Br J Pharmacol 1998; 124:1587\u20131590.","journal-title":"Br J Pharmacol"},{"key":"6_CR94","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000138645","volume":"40","author":"S. Guarini","year":"1990","unstructured":"Guarini S, Tagliavini S, Bazzani C et al. Intracerebroventricular injection of hemicolinium-3 prevents the ACTH-induced, but not the physostigmine-induced, reversal of hemorrhagic shock in rats. Pharmacology 1990; 40:85\u201389.","journal-title":"Pharmacology"},{"key":"6_CR95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0143-4179(86)90060-0","volume":"8","author":"S. Guarini","year":"1986","unstructured":"Guarini S, Rompianesi E, Ferrari W et al. Influence of vagotomy and of atropine on the anti-shock effect of adrenocorticotropin. Neuropeptides 1986; 8:19\u201324.","journal-title":"Neuropeptides"},{"key":"6_CR96","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1476-5381.1989.tb16885.x","volume":"98","author":"S. Guarini","year":"1989","unstructured":"Guarini S, Tagliavini S, Ferrari W et al. Reversal of haemorrhagic shock in rats by cholinomimetic drugs. Br J Pharmacol 1989; 98:218\u2013824.","journal-title":"Br J Pharmacol"},{"key":"6_CR97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0300-9572(91)90078-D","volume":"21","author":"J. Savi\u0107","year":"1991","unstructured":"Savi\u0107 J, Varagi\u0107 VM, Proki\u0107 DJ et al. The life-saving effect of physostigmine in haemorrhagic shock. Resuscitation 1991; 21:57\u201360.","journal-title":"Resuscitation"},{"key":"6_CR98","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0006-8993(94)91298-X","volume":"660","author":"F. Onat","year":"1994","unstructured":"Onat F, Aslan N, G\u00f6ren Z et al. Reversal of hemorrhagic shock in rats by oxotremorine: the role of muscarinic and nicotinic receptors and AV3V region. Brain Res 1994; 660:261\u2013266.","journal-title":"Brain Res"},{"key":"6_CR99","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0300-9572(93)90118-A","volume":"25","author":"C. Bazzani","year":"1993","unstructured":"Bazzani C, Balugani A, Bertolini A et al. Comparison of the effects of ACTH-(1\u201324), methylprednisolone, aprotinin and norepinephrine in a model of hemorrhagic shock in rats. Resuscitation 1993; 25:219\u2013226.","journal-title":"Resuscitation"},{"key":"6_CR100","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1600-0749.1996.tb00103.x","volume":"9","author":"C. Gonindard","year":"1996","unstructured":"Gonindard C, Goigoux C, Hollande E et al. The administration of an \u03b1-MSH analogue reduces the serum release of IL-1 \u03b1 and TNF \u03b1 induced by the injection of a sublethal dose of lipopolysaccharides in the BALB\/c mouse. Pigment Cell Res 1996; 9:148\u2013153.","journal-title":"Pigment Cell Res"},{"key":"6_CR101","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1749-6632.1994.tb39654.x","volume":"741","author":"J.M. Lipton","year":"1994","unstructured":"Lipton JM, Ceriani G, Macaluso A et al. Antiinflammatory effects of the neuropeptide \u03b1-MSH in acute, chronic and systemic inflammation. Ann NY Acad Sci 1994; 741:137\u2013148.","journal-title":"Ann NY Acad Sci"},{"key":"6_CR102","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1073\/pnas.0600506103","volume":"103","author":"V.A. Pavlov","year":"2006","unstructured":"Pavlov VA, Ochani M, Gallowitsch-Puerta M et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci USA 2006; 103:5219\u20135223.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR103","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cardiores.2003.10.011","volume":"61","author":"J. Vinten-Johansen","year":"2004","unstructured":"Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004; 61:481\u2013497.","journal-title":"Cardiovasc Res"},{"key":"6_CR104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","volume":"53","author":"N.G. Frangogiannis","year":"2002","unstructured":"Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53:31\u201347.","journal-title":"Cardiovasc Res"},{"key":"6_CR105","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cardiores.2003.12.023","volume":"61","author":"F. Eefting","year":"2004","unstructured":"Eefting F, Rensing B, Wigman J et al. Role of apoptosis in reperfusion injury. Cardiovasc Res 2004; 61:414\u2013426.","journal-title":"Cardiovasc Res"},{"key":"6_CR106","doi-asserted-by":"crossref","first-page":"H660","DOI":"10.1152\/ajpheart.1996.271.2.H660","volume":"271","author":"C.A. O\u2019Neill","year":"1996","unstructured":"O\u2019Neill CA, Fu LW, Halliwell B et al. Hydroxyl radical production during myocardial ischemia and reperfusion in cats. Am J Physiol Heart Circ Physiol 1996; 271:H660\u2013H667.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6_CR107","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/physrev.1999.79.2.609","volume":"79","author":"R. Bolli","year":"1999","unstructured":"Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 1999; 79:609\u2013634.","journal-title":"Physiol Rev"},{"key":"6_CR108","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1161\/01.CIR.0000124489.46660.2E","volume":"109","author":"R. Ramasamy","year":"2004","unstructured":"Ramasamy R, Hwang YC, Liu Y et al. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts. Circulation 2004; 109:1668\u20131673.","journal-title":"Circulation"},{"key":"6_CR109","doi-asserted-by":"crossref","first-page":"H543","DOI":"10.1152\/ajpheart.1999.276.2.H543","volume":"276","author":"C. Li","year":"1999","unstructured":"Li C, Browder W, Kao RL. Early activation of transcription factor NF-kB during ischemia in perfused rat heart. Am J Physiol Heart Circ Physiol 1999; 276:H543\u2013H552.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6_CR110","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0008-6363(97)00327-1","volume":"38","author":"N. Shimizu","year":"1998","unstructured":"Shimizu N, Yoshiyama M, Omura T et al. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res 1998; 38:116\u2013124.","journal-title":"Cardiovasc Res"},{"key":"6_CR111","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","volume":"61","author":"D.J. Hausenloy","year":"2004","unstructured":"Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 2004; 61:448\u2013460.","journal-title":"Cardiovasc Res"},{"key":"6_CR112","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.coph.2003.10.012","volume":"4","author":"G.V. Moukarbel","year":"2004","unstructured":"Moukarbel GV, Ayoub CM, Abchee AB. Pharmacological therapy for myocardial reperfusion injury. Curr Opin Pharmacol 2004; 4:147\u2013153.","journal-title":"Curr Opin Pharmacol"},{"key":"6_CR113","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.acvd.2008.06.013","volume":"101","author":"J.P. Monassier","year":"2008","unstructured":"Monassier JP. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options. Arch Cardiovasc Dis 2008; 101:565\u2013575.","journal-title":"Arch Cardiovasc Dis"},{"key":"6_CR114","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/cvr\/cvn317","volume":"81","author":"U. Landmesser","year":"2009","unstructured":"Landmesser U, Wollert KC, Drexler H. Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc Res 2009; 81:519\u2013527.","journal-title":"Cardiovasc Res"},{"key":"6_CR115","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0300-9572(01)00436-1","volume":"52","author":"C. Bazzani","year":"2002","unstructured":"Bazzani C, Mioni C, Ferrazza G et al. Involvement of the central nervous system in the protective effect of melanocortins in myocardial ischaemia\/reperfusion injury. Resuscitation 2002; 52:109\u2013115.","journal-title":"Resuscitation"},{"key":"6_CR116","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1089\/ars.2006.1535","volume":"9","author":"B. Juhasz","year":"2007","unstructured":"Juhasz B, Der P, Szodoray P et al. Adrenocorticotrope hormone fragment (4\u201310) attenuates the ischemia\/ reperfusion-induced cardiac injury in isolated rat hearts. Antioxid Redox Signal 2007; 9:1851\u20131861.","journal-title":"Antioxid Redox Signal"},{"key":"6_CR117","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.4049\/jimmunol.175.5.3391","volume":"175","author":"G. Colombo","year":"2005","unstructured":"Colombo G, Gatti S, Turcatti F et al. Gene expression profiling reveals multiple protective influences of the peptide \u03b1-melanocyte-stimulating hormone in experimental heart transplantation. J Immunol 2005; 175:3391\u20133401.","journal-title":"J Immunol"},{"key":"6_CR118","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.RES.61.3.429","volume":"61","author":"G. Zuanetti","year":"1987","unstructured":"Zuanetti G, De Ferrari GM, Priori SG et al. Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res 1987; 61:429\u2013435.","journal-title":"Circ Res"},{"key":"6_CR119","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.RES.68.5.1471","volume":"68","author":"E. Vanoli","year":"1991","unstructured":"Vanoli E, De Ferrari GM, Stramba-Badiale M et al. Vagal stimulation and prevention of sudden death in conscious dog with a healed myocardial infarction. Circ Res 1991; 68:1471\u20131481.","journal-title":"Circ Res"},{"key":"6_CR120","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.CIR.0000105721.71640.DA","volume":"109","author":"M. Li","year":"2004","unstructured":"Li M, Zheng C, Sato T et al. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109:120\u2013124.","journal-title":"Circulation"},{"key":"6_CR121","doi-asserted-by":"crossref","first-page":"R625","DOI":"10.1152\/ajpregu.00143.2003","volume":"286","author":"Z. Cheng","year":"2004","unstructured":"Cheng Z, Zhang H, Guo SZ et al. Differential control over postganglionic neurons in rat cardiac ganglia by NA and DmnX neurons: anatomical evidence. Am J Physiol Regul Integr Comp Physiol 2004; 286:R625\u2013R633.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"6_CR122","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1523\/JNEUROSCI.22-08-03215.2002","volume":"22","author":"Z. Cheng","year":"2002","unstructured":"Cheng Z, Guo SZ, Lipton AJ et al. Domoic acid lesions in nucleus of the solitary tract: time-dependent recovery of hypoxic ventilatory response and peripheral afferent axonal plasticity. J Neurosci 2002; 22:3215\u201326.","journal-title":"J Neurosci"},{"key":"6_CR123","unstructured":"Zhang H, Gozal D, Yu J et al. Attenuation of baroreflex control of the heart rate following domoic acid (DA) lesions in the nucleus ambiguus (NA) of the rat. Soc Neurosci Abstr 2002; 29."},{"key":"6_CR124","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1058-9813(00)00053-9","volume":"11","author":"M.R. Anderson","year":"2000","unstructured":"Anderson MR. The systemic inflammatory response in heart failure. Prog Ped Card 2000; 11:219\u2013230.","journal-title":"Prog Ped Card"},{"key":"6_CR125","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jtcvs.2008.08.020","volume":"137","author":"R.G. Katare","year":"2009","unstructured":"Katare RG, Ando M, Kakinuma Y et al. Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mithocondrial permeability transition pore independent of the bradycardiac effect. J Thorac Cardiovasc Surg 2009; 137:223\u2013231.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"6_CR126","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIRCRESAHA.108.188243","volume":"104","author":"P. Krishnamurthy","year":"2009","unstructured":"Krishnamurthy P, Rajasingh J, Lambers E et al. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 2009; 104:e9\u2013e18.","journal-title":"Circ Res"},{"key":"6_CR127","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0165-0173(02)00157-1","volume":"39","author":"R.R. Leker","year":"2002","unstructured":"Leker RR, Shohami E. Cerebral ischemia and trauma\u2014different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Rev 2002; 39:55\u201373.","journal-title":"Brain Res Rev"},{"key":"6_CR128","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1161\/01.STR.0000025518.34157.51","volume":"33","author":"D.J. Gladstone","year":"2002","unstructured":"Gladstone DJ, Black SE, Hakim AM. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002; 33:2123\u20132136.","journal-title":"Stroke"},{"key":"6_CR129","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1210\/er.2004-0014","volume":"26","author":"P.M. Wise","year":"2005","unstructured":"Wise PM, Dubal DB, Rau SW et al. Are estrogens protective or risk factors in brain injury and neurodegeneration? Re-evaluation after the women\u2019s health initiative. Endocr Rev 2005; 26:308\u2013312.","journal-title":"Endocr Rev"},{"key":"6_CR130","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.STR.0000209330.73175.34","volume":"37","author":"A. Rogalewski","year":"2006","unstructured":"Rogalewski A, Schneider A, Ringelstein EB et al. Toward a multimodal neuroprotective treatment of stroke. Stroke 2006; 37:1129\u20131136.","journal-title":"Stroke"},{"key":"6_CR131","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"H.P. Adams","year":"2007","unstructured":"Adams HP, Del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke. Stroke 2007; 38:1655\u2013711.","journal-title":"Stroke"},{"key":"6_CR132","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tins.2008.09.006","volume":"32","author":"M. Yepes","year":"2009","unstructured":"Yepes M, Roussel BD, Ali C et al. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci 2009; 32:48\u201355.","journal-title":"Trends Neurosci"},{"key":"6_CR133","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00006123-199701000-00030","volume":"40","author":"S.K. Huh","year":"1997","unstructured":"Huh SK, Lipton JM, Batjer HH. The protective effects of \u03b1-melanocyte stimulating hormone on canine brain ischemia. Neurosurgery 1997; 40:132\u2013140.","journal-title":"Neurosurgery"},{"key":"6_CR134","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0304-3940(02)01088-1","volume":"334","author":"Q. Huang","year":"2002","unstructured":"Huang Q, Tatro JB. \u03b1-Melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-\u03b1 and interleukin-1 \u03b2 gene expression following transient cerebral ischemia in mice. Neurosci Lett 2002; 334:186\u2013190.","journal-title":"Neurosci Lett"},{"key":"6_CR135","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.npep.2005.10.006","volume":"40","author":"S. Forslin Aronsson","year":"2006","unstructured":"Forslin Aronsson S, Spulber S, Popescu LM et al. \u03b1-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides 2006; 40:65\u201375.","journal-title":"Neuropeptides"},{"key":"6_CR136","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1749-6632.2003.tb03187.x","volume":"994","author":"J.B. Tatro","year":"2003","unstructured":"Tatro JB, Sinha PS. The central melanocortin system and fever. Ann N Y Acad Sci 2003; 994:246\u2013257.","journal-title":"Ann N Y Acad Sci"},{"key":"6_CR137","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00001756-200501190-00016","volume":"16","author":"S. Spulber","year":"2005","unstructured":"Spulber S, Moldovan M, Oprica M et al. \u03b1-MSH decreases core and brain temperature during global cerebral ischemia in rats. Neuroreport 2005; 16:69\u201372.","journal-title":"Neuroreport"},{"key":"6_CR138","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0006-8993(02)03368-1","volume":"955","author":"A. Gendron","year":"2002","unstructured":"Gendron A, Teitelbaum J, Cossette C et al. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res 2002; 955:85\u201397.","journal-title":"Brain Res"},{"key":"6_CR139","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1084\/jem.20021098","volume":"198","author":"K. Prass","year":"2003","unstructured":"Prass K, Meisel C, Hoflich C et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198:725\u2013736.","journal-title":"J Exp Med"},{"key":"6_CR140","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0165-5728(03)00134-6","volume":"139","author":"H.C.A. Emsley","year":"2003","unstructured":"Emsley HCA, Smith CJ, Gavin CM et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003; 139:93\u2013101.","journal-title":"J Neuroimmunol"},{"key":"6_CR141","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2377-4-2","volume":"4","author":"C.J. Smith","year":"2004","unstructured":"Smith CJ, Emsley HCA, Gavin CM et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004; 4:2.","journal-title":"BMC Neurol"},{"key":"6_CR142","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/sj.jcbfm.9600217","volume":"26","author":"H. Offner","year":"2006","unstructured":"Offner H, Subramanian S, Parker SM et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006; 26:654\u2013665.","journal-title":"J Cereb Blood Flow Metab"},{"key":"6_CR143","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.nbd.2005.05.011","volume":"20","author":"G. Zhang","year":"2005","unstructured":"Zhang G, Zhang L, Logan R et al. Decreased expression and impaired function of muscarinic acetylcholine receptors in the rat hippocampus following transient forebrain ischemia. Neurobiol Dis 2005; 20:805\u2013813.","journal-title":"Neurobiol Dis"},{"key":"6_CR144","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/STROKEAHA.106.476507","volume":"38","author":"S.J. Spencer","year":"2007","unstructured":"Spencer SJ, Mouihate A, Pittman QJ. Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation. Stroke 2007; 38:1570\u20131577.","journal-title":"Stroke"},{"key":"6_CR145","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/01.STR.0000057976.53301.69","volume":"34","author":"N. Vila","year":"2003","unstructured":"Vila N, Castillo J, D\u00e1valos A et al. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003; 34:671\u2013675.","journal-title":"Stroke"},{"key":"6_CR146","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1210\/me.8.10.1298","volume":"8","author":"K.G. Mountjoy","year":"1994","unstructured":"Mountjoy KG, Mortrud MT, Low MJ et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994; 8:1298\u20131308.","journal-title":"Mol Endocrinol"},{"key":"6_CR147","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1523\/JNEUROSCI.16-16-05182.1996","volume":"16","author":"S.J. Li","year":"1996","unstructured":"Li SJ, Varga K, Archer P et al. Melanocortin antagonists define two distinct pathways of cardiovascular control by \u03b1-and \u03b3-melanocyte-stimulating hormones. J Neurosci 1996; 16:5182\u20135188.","journal-title":"J Neurosci"},{"key":"6_CR148","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1073\/pnas.0803237105","volume":"105","author":"M. Rosas-Ballina","year":"2008","unstructured":"Rosas-Ballina M, Ochani M, Parrish WR et al. Splenic nerve is required for cholinergic anti-inflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008; 105:11008\u201311013.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Advances in Experimental Medicine and Biology","Melanocortins: Multiple Actions and Therapeutic Potential"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-6354-3_6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T10:17:55Z","timestamp":1740824275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-6354-3_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9781441963536","9781441963543"],"references-count":148,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-6354-3_6","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4419-6354-3","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}